PCI Staff Share Insights During Philly Tech Week
PCI staff served on panels to discuss technology transfer and commercialization.
Spring 2026 Penn I-Corps Cohort Completes Program
Five teams developing opportunities across climate resilience, medical devices, sustainable materials, environmental monitoring, and diagnostics recently completed this program.
Nuclear Medicine Symposium Highlights Innovation Opportunities
The program at uCity Square featured panel discussions on this key emerging area of Philadelphia’s economy.
NextUP Program Provides Impact Grant Funding for Promising Pre-commercial Penn Ideas and Technologies
Applicants must include a Penn faculty member as a lead participant and an invention disclosure must be submitted to PCI.
Meet the Penn I-Corps Spring 2026 Teams
The Spring 2026 teams have completed the Penn I-Corps program.
Craig Gravitz, JD, Joins PCI as Executive Director of PCI Ventures
Gravitz joins PCI from the Advanced Research Projects Agency for Health (ARPA‑H).
Featured Technology: Physical Neural Network for Fast, Scalable, and Power-Efficient Machine Learning Computation
This is hardware-based neural network technology that performs machine learning directly through physical circuits instead of traditional software.
Meet the 2026/2027 PCI Invention Analysts Cohort
PCI welcomes the 2026 PCI Fellows consisting of 12 outstanding trainees across Penn’s schools: Penn Engineering (6), Penn Medicine (5), and Penn Arts & Sciences (1).
Investment Funds available for Penn Startups
Penn has three investment funds available for early stage startups affiliated with the University.
T Cells Targeting Misformed Proteins to Treat Neurodegenerative and Muscular Diseases
By targeting disease-specific proteins, this antigen-specific immunotherapy aims to selectively eliminate damaged cells, potentially offering a more precise and effective treatment approach.